What is MaxCyte's deferred income?

MaxCyte (MXCT) reported deferred income of $3.27M in Q1 2026.

How has MaxCyte's deferred income changed year-over-year?

MaxCyte's deferred income decreased by 21.1% year-over-year, from $4.15M to $3.27M.

What is the long-term trend for MaxCyte's deferred income?

Over 5 years (2020 to 2025), MaxCyte's deferred income has grown at a -5.8% compound annual growth rate (CAGR), from $4.84M to $3.6M.

MaxCyte MXCT Deferred income

Deferred income at other companies

Bio-Rad LaboratoriesBIO

——

PDE

Pro-Dex, Inc.PDEX

——

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:DeferredRevenueCurrent.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's deferred income?: MaxCyte (MXCT) reported deferred income of $3.27M in Q1 2026.
How has MaxCyte's deferred income changed year-over-year?: MaxCyte's deferred income decreased by 21.1% year-over-year, from $4.15M to $3.27M.
What is the long-term trend for MaxCyte's deferred income?: Over 5 years (2020 to 2025), MaxCyte's deferred income has grown at a -5.8% compound annual growth rate (CAGR), from $4.84M to $3.6M.